"The primary aim of this guideline, commissioned by the BSG, is to review and summarise the current evidence to inform and guide clinical practice, by providing a practical framework for evidence-based management of patients."
Web site: gut.bmj.com/content/early/2...
Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a RCT
An open letter to those who know somebody and those who live with Irritable Bowel Syndrome (IBS.) No, rare Whipple’s disease isn't the underlying cause of my functional bowel problems (FGID) and other, all over the body symptoms. Stopped - L. reuteri probiotic (DSM 17938). My latest trial in an ongoing search to alleviate my IBS related symptoms (chronic dysbiosis?)
IBS? Yes/no Confused 
